Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

8 Mar 2026

Leo Pharma: MSL activity deemed promotional, triggering ABPI exam requirement (AUTH/3244/9/19)

Anonymous employee complaint about Leo’s dermatology MSLs. Panel found some MSL speaker-meeting activity was promotional, so MSLs should…

8 Mar 2026

AUTH/3363/6/20: GSK Anoro Ellipta public website page – no breach (reference information and certification upheld)

A UK health professional alleged GSK’s public Anoro Ellipta webpage promoted a POM and encouraged requests for treatment,…

8 Mar 2026

Novartis: corporate webpage pipeline table ruled to promote POMs to the public and an unlicensed medicine (AUTH/3414/11/20)

Novartis’ corporate webpage listed pipeline products with indications and trial details. PMCPA ruled it promoted two licensed POMs…

8 Mar 2026

AstraZeneca: β€œNon-promotional” EAP webinar ruled promotional and disguised promotion (Calquence) (AUTH/3521/6/21)

An invitation-only Calquence EAP β€œnon-promotional” webinar used positive case studies and lacked certified slides. PMCPA ruled it was…

8 Mar 2026

AUTH/3653/5/22: Eli Lilly v Novo Nordisk β€” GLP-1RA supply emails ruled disparaging (Clause 6.6)

Novo Nordisk emailed HCPs about GLP-1RA supply during Lilly’s Trulicity dose outage. Panel found the wording implied Lilly…

8 Mar 2026

AstraZeneca: UK employees’ LinkedIn β€˜likes’ brought US FDA approval post into ABPI Code scope (AUTH/3707/11/22)

A US-facing LinkedIn post about an FDA-approved lung cancer combo was liked/commented on by 14 UK-based AstraZeneca employees,…

8 Mar 2026

GSK: UK employees’ LinkedIn β€˜likes’ brought global Jemperli post into scope and amounted to POM promotion to the public (AUTH/3810/8/23)

Two UK-based GSK employees β€˜liked’ a LinkedIn post about US FDA approval for Jemperli + chemotherapy. Panel ruled…

8 Mar 2026

Roche: healthcare partnership website sponsorship declaration held sufficiently clear from the outset (AUTH/3893/4/24)

Complaint alleged Roche sponsorship wasn’t declared prominently from the outset on a partnership website and breached a prior…

8 Mar 2026

AUTH/2147/7/08: GlaxoSmithKline v Sanofi Pasteur MSD – Gardasil press release and PR agency emails

A Gardasil press release and related PR emails after the UK HPV tender were ruled misleading and exaggerated,…

8 Mar 2026

Anonymous v GlaxoSmithKline: POINTS COPD audit service (AUTH/2178/10/08) – No breach

Anonymous complaint questioned GSK’s POINTS COPD audit service (consent complexity, data access, inducement). PMCPA found clear separation of…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training